{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T09:10:43Z","timestamp":1792141843934,"version":"4.4.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s00417-023-06270-3","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T10:03:30Z","timestamp":1697709810000},"page":"575-582","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Demyelinating plaque-associated uveitis"],"prefix":"10.1007","volume":"262","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5667-5379","authenticated-orcid":false,"given":"Alireza","family":"Hedayatfar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasha","family":"Anvari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"C. P.","family":"Herbort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon-Phaik","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"issue":"6","key":"6270_CR1","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1111\/aos.14697","volume":"99","author":"P Casselman","year":"2021","unstructured":"Casselman P, Cassiman C, Casteels I et al (2021) Insights into multiple sclerosis-associated uveitis: a scoping review. Acta ophthalmologica 99(6):592\u2013603. https:\/\/doi.org\/10.1111\/aos.14697","journal-title":"Acta ophthalmologica"},{"issue":"2","key":"6270_CR2","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/bjophthalmol-2014-305518","volume":"99","author":"W Messenger","year":"2015","unstructured":"Messenger W, Hildebrandt L, Mackensen F et al (2015) Characterisation of uveitis in association with multiple sclerosis. Br J Ophthalmol 99(2):205\u2013209. https:\/\/doi.org\/10.1136\/bjophthalmol-2014-305518","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"6270_CR3","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/nrneurol.2011.1","volume":"7","author":"X Bosch","year":"2011","unstructured":"Bosch X, Saiz A, Ramos-Casals M, BIOGEAS Study Group (2011) Monoclonal antibody therapy-associated neurological disorders. Nature reviews. Neurology 7(3):165\u2013172. https:\/\/doi.org\/10.1038\/nrneurol.2011.1","journal-title":"Nature reviews. Neurology"},{"issue":"12","key":"6270_CR4","doi-asserted-by":"publisher","first-page":"2862","DOI":"10.1002\/1529-0131(200112)44:12<2862::aid-art474>3.0.co;2-w","volume":"44","author":"N Mohan","year":"2001","unstructured":"Mohan N, Edwards ET, Cupps TR et al (2001) Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides. Arthritis Rheum 44(12):2862\u20132869. https:\/\/doi.org\/10.1002\/1529-0131(200112)44:12%3c2862::aid-art474%3e3.0.co;2-w","journal-title":"Arthritis Rheum"},{"issue":"4","key":"6270_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1007\/s11910-017-0742-1","volume":"17","author":"E Kemanetzoglou","year":"2017","unstructured":"Kemanetzoglou E, Andreadou E (2017) CNS Demyelination with TNF-\u03b1 blockers. Curr Neurol Neurosc Rep 17(4):36. https:\/\/doi.org\/10.1007\/s11910-017-0742-1","journal-title":"Curr Neurol Neurosc Rep"},{"issue":"6","key":"6270_CR6","doi-asserted-by":"publisher","first-page":"482","DOI":"10.3109\/09273948.2010.496914","volume":"18","author":"M Papadia","year":"2010","unstructured":"Papadia M, Herbort CP (2010) Infliximab-induced demyelination causes visual disturbance mistaken for recurrence of HLA-B27-related uveitis. Ocul Immunol Inflamm 18(6):482\u2013484. https:\/\/doi.org\/10.3109\/09273948.2010.496914","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"6270_CR7","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1177\/1120672120904667","volume":"31","author":"AF AlBloushi","year":"2021","unstructured":"AlBloushi AF, Dheyab AM, Al-Swaina NF et al (2021) Clinical findings and outcomes of uveitis associated with multiple sclerosis. Europ J Ophthalmol 31(2):482\u2013490. https:\/\/doi.org\/10.1177\/1120672120904667","journal-title":"Europ J Ophthalmol"},{"issue":"12","key":"6270_CR8","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1136\/bjophthalmol-2015-307269","volume":"99","author":"H Petrushkin","year":"2015","unstructured":"Petrushkin H, Kidd D, Pavesio C (2015) Intermediate uveitis and multiple sclerosis: to scan or not to scan. Br J Ophthalmol 99(12):1591\u20131593. https:\/\/doi.org\/10.1136\/bjophthalmol-2015-307269","journal-title":"Br J Ophthalmol"},{"issue":"2","key":"6270_CR9","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1002\/ana.22366","volume":"69","author":"CH Polman","year":"2011","unstructured":"Polman CH, Reingold SC, Banwell B et al (2011) Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol 69(2):292\u2013302. https:\/\/doi.org\/10.1002\/ana.22366","journal-title":"Ann Neurol"},{"issue":"2","key":"6270_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17(2):162\u2013173. https:\/\/doi.org\/10.1016\/S1474-4422(17)30470-2","journal-title":"Lancet Neurol"},{"issue":"12","key":"6270_CR11","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1212\/wnl.38.12.1822","volume":"38","author":"F Fazekas","year":"1988","unstructured":"Fazekas F, Offenbacher H, Fuchs S et al (1988) Criteria for an increased specificity of MRI interpretation in elderly subjects with suspected multiple sclerosis. Neurology 38(12):1822\u20131825. https:\/\/doi.org\/10.1212\/wnl.38.12.1822","journal-title":"Neurology"},{"issue":"Pt 11","key":"6270_CR12","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1093\/brain\/120.11.2059","volume":"120","author":"F Barkhof","year":"1997","unstructured":"Barkhof F, Filippi M, Miller DH et al (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain: J Neurol 120(Pt 11):2059\u20132069. https:\/\/doi.org\/10.1093\/brain\/120.11.2059","journal-title":"Brain: J Neurol"},{"key":"6270_CR13","doi-asserted-by":"publisher","unstructured":"DA, Jabs, Nussenblatt RB, Rosenbaum JT, Standardization of Uveitis Nomenclature (SUN) Working Group (2005) Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Amer J Ophthalmol 140(3):509\u2013516. https:\/\/doi.org\/10.1016\/j.ajo.2005.03.057","DOI":"10.1016\/j.ajo.2005.03.057"},{"issue":"6","key":"6270_CR14","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1080\/09273940591003828","volume":"13","author":"AM Abu El-Asrar","year":"2005","unstructured":"Abu El-Asrar AM, Herbort CP, Tabbara KF (2005) Retinal vasculitis. Ocul Immunol Inflamm 13(6):415\u2013433. https:\/\/doi.org\/10.1080\/09273940591003828","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"6270_CR15","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1097\/00006982-199414050-00010","volume":"14","author":"JB Kerrison","year":"1994","unstructured":"Kerrison JB, Flynn T, Green WR (1994) Retinal pathologic changes in multiple sclerosis. Retina 14(5):445\u2013451. https:\/\/doi.org\/10.1097\/00006982-199414050-00010","journal-title":"Retina"},{"issue":"4","key":"6270_CR16","first-page":"409","volume":"38","author":"JW Prineas","year":"1978","unstructured":"Prineas JW, Wright RG (1978) Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab Investig J Tech Methods Pathol 38(4):409\u2013421","journal-title":"Lab Investig J Tech Methods Pathol"},{"issue":"8","key":"6270_CR17","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/S1474-4422(14)70101-2","volume":"13","author":"O Ciccarelli","year":"2014","unstructured":"Ciccarelli O, Barkhof F, Bodini B et al (2014) Pathogenesis of multiple sclerosis: insights from molecular and metabolic imaging. Lancet Neurol 13(8):807\u2013822. https:\/\/doi.org\/10.1016\/S1474-4422(14)70101-2","journal-title":"Lancet Neurol"},{"issue":"2","key":"6270_CR18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s00005-015-0361-y","volume":"64","author":"J Prze\u017adziecka-Do\u0142yk","year":"2016","unstructured":"Prze\u017adziecka-Do\u0142yk J, W\u0119grzyn A, Turno-Kr\u0119cicka A, Misiuk-Hoj\u0142o M (2016) Immunopathogenic Background of Pars Planitis. Arch Immunol Ther Exp 64(2):127\u2013137. https:\/\/doi.org\/10.1007\/s00005-015-0361-y","journal-title":"Arch Immunol Ther Exp"},{"issue":"9","key":"6270_CR19","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1097\/01.jnen.0000235119.52311.16","volume":"65","author":"S Hochmeister","year":"2006","unstructured":"Hochmeister S, Grundtner R, Bauer J et al (2006) Dysferlin is a new marker for leaky brain blood vessels in multiple sclerosis. J Neuropathol Exp Neurol 65(9):855\u2013865. https:\/\/doi.org\/10.1097\/01.jnen.0000235119.52311.16","journal-title":"J Neuropathol Exp Neurol"},{"issue":"2","key":"6270_CR20","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1002\/path.1434","volume":"201","author":"J Kirk","year":"2003","unstructured":"Kirk J, Plumb J, Mirakhur M, McQuaid S (2003) Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J Pathol 201(2):319\u2013327. https:\/\/doi.org\/10.1002\/path.1434","journal-title":"J Pathol"},{"issue":"8","key":"6270_CR21","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1016\/s0161-6420(93)31505-8","volume":"100","author":"SM Malinowski","year":"1993","unstructured":"Malinowski SM, Pulido JS, Goeken NE, Brown CK, Folk JC (1993) The association of HLA-B8, B51, DR2, and multiple sclerosis in pars planitis. Ophthalmology 100(8):1199\u20131205. https:\/\/doi.org\/10.1016\/s0161-6420(93)31505-8","journal-title":"Ophthalmology"},{"issue":"1","key":"6270_CR22","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/nrneurol.2016.187","volume":"13","author":"T Olsson","year":"2017","unstructured":"Olsson T, Barcellos LF, Alfredsson L (2017) Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis. Nat Rev Neurol 13(1):25\u201336. https:\/\/doi.org\/10.1038\/nrneurol.2016.187","journal-title":"Nat Rev Neurol"},{"issue":"6","key":"6270_CR23","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/s0161-6420(93)31567-8","volume":"100","author":"SM Malinowski","year":"1993","unstructured":"Malinowski SM, Pulido JS, Folk JC (1993) Long-term visual outcome and complications associated with pars planitis. Ophthalmology 100(6):818\u2013825. https:\/\/doi.org\/10.1016\/s0161-6420(93)31567-8","journal-title":"Ophthalmology"},{"issue":"1","key":"6270_CR24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.3899\/jrheum.080102","volume":"36","author":"E Jakob","year":"2009","unstructured":"Jakob E, Reuland MS, Mackensen F et al (2009) Uveitis subtypes in a german interdisciplinary uveitis center\u2013analysis of 1916 patients. J Rheumatol 36(1):127\u2013136. https:\/\/doi.org\/10.3899\/jrheum.080102","journal-title":"J Rheumatol"},{"issue":"1","key":"6270_CR25","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13075-017-1371-4","volume":"19","author":"A Jamshidi","year":"2017","unstructured":"Jamshidi A, Gharibdoost F, Vojdanian M et al (2017) A phase III, randomized, two-armed, double-blind, parallel, active controlled, and non-inferiority clinical trial to compare efficacy and safety of biosimilar adalimumab (CinnoRA\u00ae) to the reference product (Humira\u00ae) in patients with active rheumatoid arthritis. Arthritis Res Ther 19(1):168. https:\/\/doi.org\/10.1186\/s13075-017-1371-4","journal-title":"Arthritis Res Ther"},{"issue":"6","key":"6270_CR26","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1080\/09273948.2021.1900276","volume":"30","author":"M Soheilian","year":"2022","unstructured":"Soheilian M, Ebrahimiadib N, Hedayatfar A et al (2022) Efficacy of biosimilar adalimumab in the treatment of Beh\u00e7et\u2019s uveitis. Ocul Immunol Inflamm 30(6):1495\u20131500. https:\/\/doi.org\/10.1080\/09273948.2021.1900276","journal-title":"Ocul Immunol Inflamm"},{"issue":"2","key":"6270_CR27","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1080\/09273940490895344","volume":"12","author":"G Zein","year":"2004","unstructured":"Zein G, Berta A, Foster CS (2004) Multiple sclerosis-associated uveitis. Ocul Immunol Inflamm 12(2):137\u2013142. https:\/\/doi.org\/10.1080\/09273940490895344","journal-title":"Ocul Immunol Inflamm"},{"issue":"5","key":"6270_CR28","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1080\/09273948.2020.1870145","volume":"30","author":"NM Chirpaz","year":"2022","unstructured":"Chirpaz NM, Kerever SMP, Gavoille AM et al (2022) Relevance of brain MRI in patients with uveitis: retrospective cohort on 402 patients. Ocul Immunol Inflamm 30(5):1109\u20131115. https:\/\/doi.org\/10.1080\/09273948.2020.1870145","journal-title":"Ocul Immunol Inflamm"},{"issue":"4","key":"6270_CR29","doi-asserted-by":"publisher","first-page":"e0214738","DOI":"10.1371\/journal.pone.0214738","volume":"14","author":"M Azami","year":"2019","unstructured":"Azami M, YektaKooshali MH, Shohani M et al (2019) Epidemiology of multiple sclerosis in Iran: a systematic review and meta-analysis. PloS One 14(4):e0214738. https:\/\/doi.org\/10.1371\/journal.pone.0214738","journal-title":"PloS One"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-023-06270-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00417-023-06270-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-023-06270-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T09:06:03Z","timestamp":1707123963000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00417-023-06270-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,19]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["6270"],"URL":"https:\/\/doi.org\/10.1007\/s00417-023-06270-3","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,19]]},"assertion":[{"value":"3 July 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for this study was obtained from the Research Ethics Committees of Iran University of Medical Sciences (Research Ethics Committees Certificate: IR.IUMS.REC.1402.032).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the Research Ethics Committees of Iran University of Medical Sciences and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Research involving human participants and\/or animals"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}